Triptophenolide 25 mg | 98.00%
TargetMol
Triptophenolide is a compound isolated from Tripterygium wilfordii Hook with anti-inflammatory activity.
More Information Supplier PageTriptophenolide
Search Results
S107 2 mg | 99.63%
TargetMol
S107 is a RyR-selective 1, 4-benzothiazepine derivative that stabilizes RyR2 channels by enhancing the binding affinity of calstabin2 to mutant and/or PKA-phosphorylated channels.
More Information Supplier PageS107
S107 25 mg | 99.63%
TargetMol
S107 is a RyR-selective 1, 4-benzothiazepine derivative that stabilizes RyR2 channels by enhancing the binding affinity of calstabin2 to mutant and/or PKA-phosphorylated channels.
More Information Supplier PageS107
SHP099 hydrochloride 100 mg | 99.62%
TargetMol
SHP099 is a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor.
More Information Supplier PageSHP099 hydrochloride
VU0155041 25 mg | 100.00%
TargetMol
VU0155041 is an effective and positive allosteric modulator/allosteric agonist at mGlu4 receptors (EC50: 798/693 nM, at human/rat).
More Information Supplier PageVU0155041
KS176 2 mg | 99.55%
TargetMol
KS176 is a potent and selective inhibitor of the breast cancer resistance protein (BCRP) multidrug transporter, showing no inhibitory activity against P-gp or MRP1.
More Information Supplier PageKS176
URB602 25 mg | 99.64%
TargetMol
URB602 is a specific monoacylglycerol lipase (MGL) inhibitor, which inhibits rat brain MGL (IC50: 28±4 μM) through a noncompetitive mechanism.
More Information Supplier PageURB602
Troglitazone 10 mg | 99.36%
TargetMol
Troglitazone is a PPARγ agonist with anti-inflammatory and anti-tumor activity.
More Information Supplier PageTroglitazone
MN-64 25 mg | Purity Not Available
TargetMol
MN-64 is a tankyrases inhibitor, showed 6 nM potency against tankyrase 1, isoenzyme selectivity, and Wnt signaling inhibition.
More Information Supplier PageMN-64
PS-1145 2 mg | 97.06%
TargetMol
PS-1145
